Variant report
Variant | esv3330033 |
---|---|
Chromosome Location | chr19:44813552-44819322 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:15)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:15 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CEBPB | chr19:44818802-44818973 | HepG2 | liver: | n/a | n/a |
2 | CTCF | chr19:44814480-44814630 | GM12872 | blood: | n/a | n/a |
3 | MAFF | chr19:44813616-44813922 | K562 | blood: | n/a | n/a |
4 | MAFF | chr19:44813560-44813952 | HepG2 | liver: | n/a | n/a |
5 | MAFK | chr19:44813621-44813924 | IMR90 | lung: | n/a | chr19:44813790-44813805 |
6 | MAFK | chr19:44813792-44813811 | H1-hESC | embryonic stem cell: | n/a | n/a |
7 | MAFK | chr19:44813538-44813963 | HepG2 | liver: | n/a | chr19:44813790-44813805 |
8 | MAFK | chr19:44813578-44813958 | HepG2 | liver: | n/a | chr19:44813790-44813805 |
9 | MAFK | chr19:44813690-44813862 | Hela-S3 | cervix: | n/a | chr19:44813790-44813805 |
10 | MAFK | chr19:44813776-44813782 | K562 | blood: | n/a | n/a |
11 | MEF2A | chr19:44817289-44817638 | GM12878 | blood: | n/a | n/a |
12 | POLR2A | chr19:44813893-44813987 | HUVEC | blood vessel: | n/a | n/a |
13 | POLR2A | chr19:44815947-44816101 | GM12878 | blood: | n/a | n/a |
14 | STAT3 | chr19:44815050-44815155 | MCF10A-Er-Src | breast: | n/a | n/a |
15 | ZNF384 | chr19:44817418-44817619 | GM12878 | blood: | n/a | n/a |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ZNF235 | TF binding region |
ENSG00000167384 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs138955864 | chr19:44813553-44813554 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
2 | rs77701217 | chr19:44813582-44813583 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs115529199 | chr19:44813615-44813616 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs575390896 | chr19:44813628-44813629 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs28382349 | chr19:44813678-44813679 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs556460589 | chr19:44813691-44813692 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs10413396 | chr19:44813702-44813703 | Enhancers | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs186373523 | chr19:44813708-44813709 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
9 | rs538654279 | chr19:44813751-44813752 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs558863607 | chr19:44813941-44813942 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs370774220 | chr19:44813960-44813961 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs189612368 | chr19:44814030-44814031 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs143344223 | chr19:44814044-44814045 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs559822357 | chr19:44814057-44814058 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs573905101 | chr19:44814058-44814059 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs370735710 | chr19:44814061-44814062 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs147135723 | chr19:44814097-44814098 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs542812584 | chr19:44814098-44814099 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs898175 | chr19:44814100-44814101 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs140336690 | chr19:44814135-44814136 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs74390979 | chr19:44814136-44814137 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs564888997 | chr19:44814269-44814270 | ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
23 | rs112015996 | chr19:44814284-44814285 | ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
24 | rs547446365 | chr19:44814333-44814334 | ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
25 | rs142749118 | chr19:44814340-44814341 | ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
26 | rs530245475 | chr19:44814356-44814357 | ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
27 | rs144496422 | chr19:44814388-44814389 | ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
28 | rs12977638 | chr19:44814402-44814403 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs898176 | chr19:44814474-44814475 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs558719417 | chr19:44814476-44814477 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs370178055 | chr19:44814508-44814509 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs367630467 | chr19:44814533-44814534 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs58715603 | chr19:44814565-44814566 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs574948973 | chr19:44814569-44814570 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs542847374 | chr19:44814589-44814590 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs556391400 | chr19:44814596-44814597 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs576446701 | chr19:44814602-44814603 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs549458049 | chr19:44814626-44814627 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs564754255 | chr19:44814629-44814630 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs572027768 | chr19:44814703-44814704 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs574693927 | chr19:44814704-44814705 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs3056455 | chr19:44814705-44814706 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs898177 | chr19:44814731-44814732 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
44 | rs2249402 | chr19:44814779-44814780 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
45 | rs181452042 | chr19:44814788-44814789 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs2722711 | chr19:44814843-44814844 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
47 | rs186284843 | chr19:44814962-44814963 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs532699967 | chr19:44814976-44814977 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs552857577 | chr19:44815006-44815007 | ZNF genes & repeats Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs565871988 | chr19:44815040-44815041 | ZNF genes & repeats Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Myelodysplastic syndrome | 17634407 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chordoma | 21602918 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Cancer | 21637783 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Cancer | 20164919 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Prostate cancer | 18632612 | CNVD |
Autism | 22495311 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Ductal carcinoma | 22052326 | CNVD |
Congenital nephrotic syndrome | 18421352 | CNVD |
Astrocytoma | 17934521 | CNVD |
Leukemia | 17361228 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Breast cancer | 21858162 | CNVD |
Breast cancer | 17603634 | CNVD |
Glioma | 21971842 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
renal disease | 20603712 | CNVD |
Salivary gland adenoid cystic carcinoma | 17545515 | CNVD |
Breast cancer | 16608533 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Breast cancer | 21364760 | CNVD |
Chordoma | 18071362 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Wilms tumour | 21544195 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Bladder cancer | 21909424 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Lung cancer | 18438408 | CNVD |
Astrocytoma | 22246337 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Cancer | 20164920 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Ovarian cancer | 20800559 | CNVD |
Ovarian clear cell carcinoma | 19293255 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 16272173 | CNVD |
Spondylocostal dysostosis | 21085971 | CNVD |
Nicotine metabolism | 21956041 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Breast cancer | 17133270 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Colorectal cancer | 20459617 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr19:44813400-44814200 | Enhancers | HSMMtube | muscle |
2 | chr19:44813800-44814200 | Weak transcription | Skeletal Muscle Male | skeletal muscle |
3 | chr19:44814200-44814400 | ZNF genes & repeats | Skeletal Muscle Male | skeletal muscle |
4 | chr19:44814400-44815000 | Weak transcription | Skeletal Muscle Male | skeletal muscle |
5 | chr19:44814600-44824600 | Weak transcription | Skeletal Muscle Female | skeletal muscle |
6 | chr19:44815000-44815400 | ZNF genes & repeats | Ovary | ovary |
7 | chr19:44817000-44818400 | Enhancers | Primary B cells from peripheral blood | blood |
8 | chr19:44818000-44819000 | ZNF genes & repeats | Duodenum Smooth Muscle | Duodenum |